Effect of natural sequence variation at the H-2L(d)-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition

Journal of General Virology

Volumn 77, Issue 10, 1996, Pages 2615-2623

  Lyons, Paul A ^a,b   Allan, Jane E ^a   Carrello, Claudio ^a,c   Shellam, Geoffrey R ^a   Scalzo, Anthony A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CROSS REACTING ANTIGEN; EPITOPE; VIRUS ANTIGEN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS IMMUNITY;

ANIMALIA; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0029997167     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-10-2615     Document Type: Article

References (41)

1. Allan, J. E. & Shellam, G. R. (1984). Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Archives of Virology 81, 139-150.
2. Apolloni, A., Moss, D., Stumm, R., Burrows, S., Misko, I., Schmidt, C. & Sculley, T. (1992). Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. European Journal of Immunology 22, 183-189.
3. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., de Carli, M., Fiaccadori, F. & Ferrari, C. (1994). Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410.
4. Booth, T. W. M., Scalzo, A. A., Carrello, C., Lyons, P. A., Farrell, H. E., Singleton, G. R. & Shellam, G. R. (1993). Molecular and biological characterisation of new strains of murine cytomegalovirus isolated from wild mice. Archives of Virology 132, 209-220.
5. Chalmer, J. E., Mackenzie, J. S. & Stanley, N. F. (1977). Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. Journal of General Virology 37, 107-114.
6. ds: sequence motif, quantitative binding, and molecular modeling of the complex. Journal of Experimental Medicine. 176, 1681-1692.
7. de Campos-Lima, P. O., Levitsky, V., Brooks, J., Lee, S. P., Hu, L. F., Rickinson, A. B. & Masucci, M. G. (1994). T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. Journal of Experimental Medicine 179, 1297-1305.
8. Del Val, M., Volkmer, H., Rothbard, J. B., Jonjic, S., Messerle, M., Schickedanz, J., Reddehase, M. J. & Koszinowski, U. H. (1988). Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. Journal of Virology 62, 3965-3972.
9. Del Val, M., Schlict, H.-J., Ruppert, T., Reddehase, M. J. & Koszinowski, U. H. (1991 a). Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153.
10. Del Val, M., Schlicht, H.-J., Volkmer, H., Messerle, M., Reddehase, M. J. & Koszinowski, U. H. (1991b). Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. Journal of Virology 65, 3641-3646.
11. Drew, W. L., Sweet, E. S., Miner, R. C. & Mocarski, E. S. (1984). Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. Journal of Infectious Diseases 150, 952-953.
12. Dutz, J. P., Walden, P. R. & Eisen, H. N. (1992). Effects of cognate peptides on cytolytic and proliferative activities of cloned cytotoxic T lymphocytes. International Immunology 4, 571-580.
13. Ho, M. (1980). Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infection and Immunity 27, 767-776.
14. Ho, M. (1991). Cytomegalovirus: Biology and Infection. New York: Plenum Medical Book Company.
15. Hodgkin, P. A., Scalzo, A. A., Swaminathan, N., Price, P. & Shellam, G. R. (1988). Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. Journal of Virological Methods 22, 215-230.
16. Hudson, J. B. (1979). The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62, 1-29.
17. Jameson, S. C. & Bevan, M. J. (1995). T cell receptor antagonists and partial agonists. Immunity 2, 1-11.
18. Jonjic, S., Del Val, M., Keil, G. M., Reddehase, M. J. & Koszinowski, U. H. (1988). A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. Journal of Virology 62, 1653-1658.
19. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179, 1713-1717.
20. Kageyama, S., Tsomides, T. J., Sykulev, Y. & Eisen, H. N. (1995). Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. Journal of Immunology 154, 567-576.
21. Keil, G. M., Ebeling-Keil, A. & Koszinowski, U. H. (1987). Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. Journal of Virology 61, 1901-1908.
22. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Köppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E. & McMichael, A. J. (1994). Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403-407.
23. Koszinowski, U. H., Keil, G. M., Schwarz, H., Schickedanz, J. & Reddehase, M. J. (1987). A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes. Journal of Experimental Medicine 166, 289-294.
24. Koszinowski, U. H., Del Val, M. & Reddehase, M. J. (1990). Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Current Topics in Microbiology and Immunology 154, 189-220.
25. Koszinowski, U. H., Reddehase, M. J. & Del Val, M. (1992). Principles of cytomegalovirus antigen presentation in vitro and in vivo. Seminars in Immunology 4, 71-79.
26. Lewicki, H., Tishon, A., Borrow, P., Evans, C. F., Gairin, J. E., Hahn, K. M., Jewell, D. A., Wilson, I. A. & Oldstone, M. B. A. (1995 a). CTL escape viral variants. I. Generation and molecular characterization. Virology 210, 29-40.
27. Lewicki, H. A., Von Herrath, M. G., Evans, C. F., Whitton, J. L. & Oldstone, M. B. A. (1995 b). CTL escape viral variants. II. Biologic activity in vivo. Virology 211, 443-450.
28. Mocarski, E., Post, L. E. & Roizman, B. (1980). Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22, 243-255.
29. Moskophidis, D. & Zinkernagel, R. M. (1995). Immunobiology of cytotoxic T-cell escape mutants of Iymphocytic chroriomeningitis virus. Journal of Virology 69, 2187-2193.
30. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R. & McMichael, A. J. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
31. Pircher, H., Moskophidis, D., Rohrer, U., Bürki, K., Hengartner, H. & Zinkernagel, R. M. (1990). Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629-633.
32. Reddehase, M. J. & Koszinowski, U. H. (1984). Significance of herpes-virus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312, 369-371.
33. Reddehase, M. J. & Koszinowski, U. H. (1991). Redistribution of critical major histocompatibility complex and T cell receptor-binding functions of residues in an antigenic sequence after biterminal substitution. European Journal of Immunology 21, 1697-1701.
34. Reddehase, M. J., Weiland, F., Münch, K., Jonjic, S., Lüske, A. & Koszinowski, U. H. (1985). Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. Journal of Virology 55, 264-273.
35. Reddehase, M. J., Rothbard, J. B. & Koszinowski, U. H. (1989). A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337, 651-653.
36. Scalzo, A. A., Elliott, S. L., Cox, J., Gardner, J., Moss, D. J. & Suhrbier, A. (1995 a). Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). Journal of Virology 69, 1306-1309.
37. Scalzo, A. A., Forbes, C. A., Davis-Poynter, N. J., Farrell, H. E. & Lyons, P.A. (1995 b). DNA sequence and transcriptional analysis of the glycoprotein M (gM) gene of murine cytomegalovirus. Journal of General Virology 76, 2895-2901.
38. Staczek, J. (1990). Animal cytomegaloviruses. Microbiological Reviews 54, 247-265.
39. + cytotoxic T cells: implications for vaccine design. Proceedings of the National Academy of Sciences, USA 92, 5845-5849.
40. Volkmer, H., Bertholet, C., Jonjic, S., Wittek, R. & Koszinowski, U. H. (1987). Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus. Journal of Experimental Medicine 166, 668-677.
41. Xu, J., Lyons, P. A., Carter, M. D., Booth, T. W. M., Davis-Poynter, N. J., Shellam, G. R. & Scalzo, A. A. (1996). Assessment of antigenicity and genetic variation of glycoprotein B (gB) of murine cytomegalovirus. Journal of General Virology 77, 49-59.